Not applicableUnknownNCT02355600What this trial is testingOocyte Recovery During Tamoxifen Adjuvant TherapyWho this might be right forBreast Cancer Instituto de Investigacion Sanitaria La Fe 20
Testing effectiveness (Phase 2)Study completedNCT02978495What this trial is testingNeoadjuvant Carboplatin in Triple Negative Breast CancerWho this might be right forBRCA1 Hereditary Breast and Ovarian Cancer Syndrome Barretos Cancer Hospital 154
Testing effectiveness (Phase 2)Looking for participantsNCT01174121What this trial is testingImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic CancerWho this might be right forMetastatic Colorectal CancerMetastatic Pancreatic CancerMetastatic Ovarian Cancer+2 more National Cancer Institute (NCI) 332
Early research (Phase 1)Ended earlyNCT05827614What this trial is testingStudy of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene AmplificationsWho this might be right forTriple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more Boundless Bio, Inc. 85
Early research (Phase 1)Study completedNCT02009449What this trial is testingPegilodecakin (LY3500518) in Participants With Advanced Solid TumorsWho this might be right forMelanomaProstate CancerOvarian Cancer+6 more Eli Lilly and Company 353
Early research (Phase 1)Ended earlyNCT04244552What this trial is testingA Phase 1b Trial of ATRC-101 in Adults With Advanced Solid MalignanciesWho this might be right forBreast CancerColorectal CancerOvarian Cancer+13 more Atreca, Inc. 87
Not applicableStudy completedNCT06582849What this trial is testingEnhanced Assistance During Radiotherapy for Unmet Essential NeedsWho this might be right forBone CancerBrain CancerColorectal Cancer+24 more Washington University School of Medicine 33
Testing effectiveness (Phase 2)UnknownNCT02052128What this trial is testingPhase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing CancersWho this might be right forProgesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy Arno Therapeutics 60
Early research (Phase 1)Looking for participantsNCT06293898What this trial is testingOpen Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsWho this might be right forEndometrial CancerCervical CancerOvarian Cancer+7 more SystImmune Inc. 280
Very early researchStudy completedNCT02013492What this trial is testingPropranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By SurgeryWho this might be right forMale Breast CancerRecurrent MelanomaStage IV Breast Cancer+5 more William Carson 1
Testing effectiveness (Phase 2)Ended earlyNCT02669914What this trial is testingMEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived TumorsWho this might be right forNon-Small Cell Lung CancerNonsmall Cell Lung CancerBreast Cancer+15 more Washington University School of Medicine 4
Not applicableLooking for participantsNCT07224464What this trial is testingThe Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.Who this might be right forMetastatic Solid TumorsStage 4 Cancer New Phase Ltd. 12
Not applicableUnknownNCT01273909What this trial is testingOutcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema TreatmentWho this might be right forBreast CancerHereditary Breast/Ovarian Cancer (brca1, brca2)Acquired Lymphedema+1 more The National Institute of Lymphology 1,000
Early research (Phase 1)Looking for participantsNCT06307249What this trial is testingPrecision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNAWho this might be right forCancerSolid TumorColorectal Cancer+7 more Lebanese University 50
Early research (Phase 1)Looking for participantsNCT04282044What this trial is testingStudy of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesWho this might be right forSolid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more BioEclipse Therapeutics 60
Not applicableActive Not RecruitingNCT04125914What this trial is testingWeight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome FamiliesWho this might be right forHereditary Breast CarcinomaHereditary Ovarian CarcinomaLynch Syndrome M.D. Anderson Cancer Center 384
Early research (Phase 1)Study completedNCT04925284What this trial is testingStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)Who this might be right forNon Small Cell Lung CancerCervical CancerSCCHN+8 more Exelixis 269
Testing effectiveness (Phase 2)Study completedNCT05700669What this trial is testingStudy to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid TumorsWho this might be right forMetastatic Castration-resistant Prostate CancerRecurrent Epithelial Ovarian CancerBreast Cancer Valerio Therapeutics 3
Testing effectiveness (Phase 2)Looking for participantsNCT06580002What this trial is testingRepurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialWho this might be right forBreast CancerSarcomaGastric Cancer+19 more University of California, Irvine 75
Early research (Phase 1)Study completedNCT02144051What this trial is testingPhase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor TumorsWho this might be right forAdvanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor AstraZeneca 32